Private Advisor Group LLC Has $497,000 Stake in Chemed Co. (NYSE:CHE)

Private Advisor Group LLC raised its stake in Chemed Co. (NYSE:CHE) by 54.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 916 shares of the company’s stock after acquiring an additional 324 shares during the period. Private Advisor Group LLC’s holdings in Chemed were worth $497,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of CHE. Norges Bank acquired a new stake in shares of Chemed in the 4th quarter valued at $92,359,000. TD Asset Management Inc grew its stake in Chemed by 164.3% during the fourth quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock worth $120,328,000 after buying an additional 127,934 shares during the last quarter. Epoch Investment Partners Inc. increased its holdings in shares of Chemed by 85.2% during the fourth quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company’s stock worth $88,977,000 after buying an additional 70,001 shares in the last quarter. Impax Asset Management Group plc raised its stake in shares of Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after acquiring an additional 51,974 shares during the last quarter. Finally, ProShare Advisors LLC boosted its holdings in shares of Chemed by 6,288.9% in the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after acquiring an additional 49,808 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the transaction, the director now owns 3,446 shares in the company, valued at $1,991,615.70. The disclosure for this sale can be found here. Insiders have sold 6,744 shares of company stock valued at $3,828,231 over the last three months. 3.32% of the stock is owned by insiders.

Chemed Price Performance

CHE stock opened at $577.59 on Thursday. The business has a fifty day moving average price of $567.45 and a 200 day moving average price of $578.35. Chemed Co. has a fifty-two week low of $497.36 and a fifty-two week high of $654.62. The stock has a market capitalization of $8.74 billion, a price-to-earnings ratio of 31.09, a P/E/G ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $4.71 earnings per share. On average, equities analysts expect that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. Chemed’s dividend payout ratio is presently 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.